Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 416

1.

The diagnostic performance of renal function-adjusted D-dimer testing in individuals suspected of venous thromboembolism.

Ten Cate V, Nagler M, Panova-Noeva M, Eggebrecht L, Arnold N, Lamparter H, Hermanns MI, Ten Cate H, Prins MH, Espinola-Klein C, Münzel T, Lackner KJ, Wild PS, Prochaska JH.

Haematologica. 2019 Mar 14. pii: haematol.2018.213322. doi: 10.3324/haematol.2018.213322. [Epub ahead of print]

2.

Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice.

Posthuma JJ, Posma JJN, van Oerle R, Leenders P, van Gorp RH, Jaminon AMG, Mackman N, Heitmeier S, Schurgers LJ, Ten Cate H, Spronk HMH.

Sci Rep. 2019 Mar 7;9(1):3909. doi: 10.1038/s41598-019-40602-w.

3.

Prognostic Hemostasis Biomarkers in Acute Ischemic Stroke.

Donkel SJ, Benaddi B, Dippel DWJ, Ten Cate H, de Maat MPM.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):360-372. doi: 10.1161/ATVBAHA.118.312102.

4.

D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications.

Favresse J, Lippi G, Roy PM, Chatelain B, Jacqmin H, Ten Cate H, Mullier F.

Crit Rev Clin Lab Sci. 2018 Dec;55(8):548-577. doi: 10.1080/10408363.2018.1529734.

PMID:
30694079
5.

Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution.

Grottke O, van Ryn J, Zentai C, Gan G, Honickel M, Rossaint R, Ten Cate H, Spronk HMH.

PLoS One. 2019 Jan 7;14(1):e0209350. doi: 10.1371/journal.pone.0209350. eCollection 2019.

6.

Direct oral anticoagulants and vitamin K antagonists are linked to differential profiles of cardiac function and lipid metabolism.

Eggebrecht L, Prochaska JH, Tröbs SO, Schwuchow-Thonke S, Göbel S, Diestelmeier S, Schulz A, Arnold N, Panova-Noeva M, Koeck T, Rapp S, Gori T, Lackner KJ, Ten Cate H, Münzel T, Wild PS.

Clin Res Cardiol. 2019 Jan 2. doi: 10.1007/s00392-018-1408-y. [Epub ahead of print]

PMID:
30604046
7.

Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based Experiment.

Leader A, Ten Cate V, Ten Cate-Hoek AJ, Spectre G, Beckers EAM, Raanani P, Giaccherini C, Pereg D, Schouten HC, Falanga A, Ten Cate H.

Thromb Haemost. 2019 Jan;119(1):163-174. doi: 10.1055/s-0038-1676520. Epub 2018 Dec 31.

PMID:
30597510
8.

Assessment and determinants of whole blood and plasma fibrinolysis in patients with mild bleeding symptoms.

Vries MJA, Macrae F, Nelemans PJ, Kuiper GJAJM, Wetzels RJH, Bowman P, Verhezen PWM, Ten Cate H, Ariëns RAS, Henskens YMC.

Thromb Res. 2019 Feb;174:88-94. doi: 10.1016/j.thromres.2018.12.004. Epub 2018 Dec 4.

PMID:
30579151
9.

Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps.

Leader A, Ten Cate H, Spectre G, Beckers EAM, Falanga A.

Crit Rev Oncol Hematol. 2018 Dec;132:76-88. doi: 10.1016/j.critrevonc.2018.09.014. Epub 2018 Sep 29. Review.

PMID:
30447929
10.

Intake of Vitamin K Antagonists and Worsening of Cardiac and Vascular Disease: Results From the Population-Based Gutenberg Health Study.

Eggebrecht L, Prochaska JH, Schulz A, Arnold N, Jünger C, Göbel S, Laubert-Reh D, Binder H, Beutel ME, Pfeiffer N, Blankenberg S, Lackner KJ, Spronk HM, Ten Cate H, Münzel T, Wild PS.

J Am Heart Assoc. 2018 Sep 4;7(17):e008650. doi: 10.1161/JAHA.118.008650.

11.

Preoperative screening for bleeding disorders: A comprehensive laboratory assessment of clinical practice.

Vries MJ, van der Meijden PE, Kuiper GJ, Nelemans PJ, Wetzels RJ, van Oerle RG, Lancé MD, Ten Cate H, Henskens YM.

Res Pract Thromb Haemost. 2018 Jul 27;2(4):767-777. doi: 10.1002/rth2.12114. eCollection 2018 Oct.

12.

Protease-activated receptors are potential regulators in the development of arterial endofibrosis in high-performance athletes.

Posthuma JJ, Posma JJN, Schep G, Bender MMH, van Oerle R, van der Wal AC, Ten Cate H, Spronk HMH.

J Vasc Surg. 2018 Oct 9. pii: S0741-5214(18)31630-6. doi: 10.1016/j.jvs.2018.05.220. [Epub ahead of print]

PMID:
30314721
13.

Individually shortened duration versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome: a cost-effectiveness analysis.

Amin EE, Ten Cate-Hoek AJ, Bouman AC, Meijer K, Tick L, Middeldorp S, Mostard G, Ten Wolde M, van den Heiligenberg S, van Wissen S, van de Poel M, Villalta S, Serné E, Otten HM, Klappe E, Prandoni P, Prins MH, Ten Cate H, Joore MA.

Lancet Haematol. 2018 Nov;5(11):e512-e519. doi: 10.1016/S2352-3026(18)30151-0. Epub 2018 Oct 9.

PMID:
30314712
14.

Shifts of Transfusion Demand in Cardiac Surgery After Implementation of Rotational Thromboelastometry-Guided Transfusion Protocols: Analysis of the HEROES-CS (HEmostasis Registry of patiEntS in Cardiac Surgery) Observational, Prospective Open Cohort Database.

Kuiper GJAJM, van Egmond LT, Henskens YMC, Roekaerts PM, Maessen JG, Ten Cate H, Buhre WF, Lancé MD.

J Cardiothorac Vasc Anesth. 2019 Feb;33(2):307-317. doi: 10.1053/j.jvca.2018.08.203. Epub 2018 Aug 29.

15.

Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndrome.

Ratzon R, Tamir S, Friehmann T, Livneh N, Dudnik E, Rozental A, Hamburger-Avnery O, Pereg D, Derazne E, Brenner B, Raanani P, Ten Cate H, Spectre G, Leader A.

J Thromb Thrombolysis. 2019 Jan;47(1):121-128. doi: 10.1007/s11239-018-1747-6.

PMID:
30255420
16.

Cardiovascular risk factors are important determinants of platelet-dependent thrombin generation in adult survivors of childhood cancer.

Panova-Noeva M, Neu MA, Eckerle S, Spix C, Schneider A, Schmidtmann I, Spronk HM, Pfeiffer N, Beutel M, Lackner KJ, Münzel T, Ten Cate H, Merzenich H, Faber J, Wild PS.

Clin Res Cardiol. 2019 Apr;108(4):438-447. doi: 10.1007/s00392-018-1374-4. Epub 2018 Sep 22.

PMID:
30244327
17.

Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis.

Amin EE, Bistervels IM, Meijer K, Tick LW, Middeldorp S, Mostard G, van de Poel M, Serné EH, Otten HM, Klappe EM, Joore MA, Ten Cate H, Ten Wolde M, Ten Cate-Hoek AJ.

Blood. 2018 Nov 22;132(21):2298-2304. doi: 10.1182/blood-2018-03-836783. Epub 2018 Sep 20.

18.

The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.

Ten Cate H, Lensing AWA, Weitz JI, Middeldorp S, Beyer-Westendorf J, Kubitza D, Brighton T, Raskob GE, Mismetti P, Prandoni P, Gebel M, Prins MH.

Thromb Res. 2018 Oct;170:75-83. doi: 10.1016/j.thromres.2018.08.008. Epub 2018 Aug 15.

PMID:
30121419
19.

Tissue factor (:Factor VIIa) in the heart and vasculature: More than an envelope.

D'Alessandro E, Posma JJN, Spronk HMH, Ten Cate H.

Thromb Res. 2018 Aug;168:130-137. doi: 10.1016/j.thromres.2018.06.020. Epub 2018 Jun 28. Review.

PMID:
30064684
20.

Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction.

Nagler M, Ten Cate H, Prins MH, Ten Cate-Hoek AJ.

Res Pract Thromb Haemost. 2018 Feb 3;2(2):299-309. doi: 10.1002/rth2.12079. eCollection 2018 Apr.

21.

The coagulation system in atherothrombosis: Implications for new therapeutic strategies.

Olie RH, van der Meijden PEJ, Ten Cate H.

Res Pract Thromb Haemost. 2018 Feb 19;2(2):188-198. doi: 10.1002/rth2.12080. eCollection 2018 Apr.

22.

No Association between Thrombin Generation and Intra-Plaque Haemorrhage in Symptomatic Carotid Atherosclerotic Plaques: The Plaque at RISK (PARISK) Study.

Crombag GAJC, Spronk HM, Nelemans P, Schreuder FHBM, Truijman MTB, van Dijk AC, de Rotte AAJ, Liem MI, Daemen MJAP, van der Steen AFW, Mess WH, Nederkoorn PJ, Hendrikse J, van der Lugt A, Wildberger JE, Ten Cate H, van Oostenbrugge RJ, Kooi ME.

Thromb Haemost. 2018 Aug;118(8):1461-1469. doi: 10.1055/s-0038-1666858. Epub 2018 Jul 4.

PMID:
29972860
23.

Sustained atrial fibrillation increases the risk of anticoagulation-related bleeding in heart failure.

Prochaska JH, Göbel S, Nagler M, Knöpfler T, Eggebrecht L, Lamparter H, Panova-Noeva M, Keller K, Coldewey M, Bickel C, Lauterbach M, Hardt R, Espinola-Klein C, Ten Cate H, Rostock T, Münzel T, Wild PS.

Clin Res Cardiol. 2018 Dec;107(12):1170-1179. doi: 10.1007/s00392-018-1293-4. Epub 2018 Jun 9.

PMID:
29948286
24.

Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy.

Baaten CCFMJ, Moenen FCJI, Henskens YMC, Swieringa F, Wetzels RJH, van Oerle R, Heijnen HFG, Ten Cate H, Holloway GP, Beckers EAM, Heemskerk JWM, van der Meijden PEJ.

Haematologica. 2018 Sep;103(9):1557-1567. doi: 10.3324/haematol.2017.185165. Epub 2018 Jun 7.

25.

Development and Validation of a Practical Two-Step Prediction Model and Clinical Risk Score for Post-Thrombotic Syndrome.

Amin EE, van Kuijk SMJ, Joore MA, Prandoni P, Ten Cate H, Ten Cate-Hoek AJ.

Thromb Haemost. 2018 Jul;118(7):1242-1249. doi: 10.1055/s-0038-1655743. Epub 2018 Jun 4.

PMID:
29864783
26.

Clinical and economic impact of compression in the acute phase of deep vein thrombosis.

Amin EE, Joore MA, Ten Cate H, Meijer K, Tick LW, Middeldorp S, Mostard GJM, Ten Wolde M, van den Heiligenberg SM, van Wissen S, van de Poel MHW, Villalta S, Serné EH, Otten HM, Klappe EH, Prandoni P, Ten Cate-Hoek AJ.

J Thromb Haemost. 2018 Jun 1. doi: 10.1111/jth.14163. [Epub ahead of print]

PMID:
29856509
27.

Comparison of EQ-5D and SF-36 in untreated patients with symptoms of intermittent claudication.

Vaidya A, Kleinegris MC, Severens JL, Ramaekers BL, Ten Cate-Hoek AJ, Ten Cate H, Joore MA.

J Comp Eff Res. 2018 Jun;7(6):535-548. doi: 10.2217/cer-2017-0029. Epub 2018 Jun 1.

PMID:
29855189
28.

Pleiotropic effects of the hemostatic system.

Kremers BMM, Ten Cate H, Spronk HMH.

J Thromb Haemost. 2018 May 31. doi: 10.1111/jth.14161. [Epub ahead of print] Review.

PMID:
29851288
29.

Direct oral anticoagulants: When to consider laboratory testing?

Ten Cate H, Olie RH, Ten Cate-Hoek AJ, Henskens YMC.

Int J Lab Hematol. 2018 May;40 Suppl 1:30-33. doi: 10.1111/ijlh.12816. Review.

PMID:
29741249
30.

Clinical Determinants of Thrombin Generation Measured in Presence and Absence of Platelets-Results from the Gutenberg Health Study.

Panova-Noeva M, Schulz A, Spronk HM, Beicht A, Laubert-Reh D, van Oerle R, Arnold N, Prochaska JH, Blettner M, Beutel M, Pfeiffer N, Münzel T, Lackner KJ, Ten Cate H, Wild PS.

Thromb Haemost. 2018 May;118(5):873-882. doi: 10.1055/s-0038-1641565. Epub 2018 Apr 3.

PMID:
29614519
31.

Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction.

Borst O, Münzer P, Alnaggar N, Geue S, Tegtmeyer R, Rath D, Droppa M, Seizer P, Heitmeier S, Heemskerk JWM, Jennings LK, Storey RF, Angiolillo DJ, Rocca B, Spronk H, Ten Cate H, Gawaz M, Geisler T.

Blood Adv. 2018 Mar 27;2(6):715-730. doi: 10.1182/bloodadvances.2017013573.

32.

Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients.

Mackman N, Spronk HMH, Stouffer GA, Ten Cate H.

Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):726-732. doi: 10.1161/ATVBAHA.117.310048. Epub 2018 Feb 15. Review. No abstract available.

PMID:
29449336
33.

A Rare Case of Intermittent Claudication Associated with Impaired Arterial Vasodilation.

Posthuma JJ, Reesink KD, Schütten M, Ghossein C, Spaanderman ME, Ten Cate H, Schep G.

Case Rep Vasc Med. 2017;2017:4868123. doi: 10.1155/2017/4868123. Epub 2017 Dec 24.

34.

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation.

Henskens YMC, Gulpen AJW, van Oerle R, Wetzels R, Verhezen P, Spronk H, Schalla S, Crijns HJ, Ten Cate H, Ten Cate-Hoek A.

Thromb J. 2018 Feb 1;16:3. doi: 10.1186/s12959-017-0160-2. eCollection 2018.

35.

Coagulation and inflammation in long-term cancer survivors: results from the adult population.

Panova-Noeva M, Schulz A, Arnold N, Hermanns MI, Prochaska JH, Laubert-Reh D, Spronk HM, Blettner M, Beutel M, Pfeiffer N, Münzel T, Lackner KJ, Ten Cate H, Wild PS.

J Thromb Haemost. 2018 Apr;16(4):699-708. doi: 10.1111/jth.13975. Epub 2018 Mar 14.

PMID:
29431889
36.

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.

Spronk HMH, Padro T, Siland JE, Prochaska JH, Winters J, van der Wal AC, Posthuma JJ, Lowe G, d'Alessandro E, Wenzel P, Coenen DM, Reitsma PH, Ruf W, van Gorp RH, Koenen RR, Vajen T, Alshaikh NA, Wolberg AS, Macrae FL, Asquith N, Heemskerk J, Heinzmann A, Moorlag M, Mackman N, van der Meijden P, Meijers JCM, Heestermans M, Renné T, Dólleman S, Chayouâ W, Ariëns RAS, Baaten CC, Nagy M, Kuliopulos A, Posma JJ, Harrison P, Vries MJ, Crijns HJGM, Dudink EAMP, Buller HR, Henskens YMC, Själander A, Zwaveling S, Erküner O, Eikelboom JW, Gulpen A, Peeters FECM, Douxfils J, Olie RH, Baglin T, Leader A, Schotten U, Scaf B, van Beusekom HMM, Mosnier LO, van der Vorm L, Declerck P, Visser M, Dippel DWJ, Strijbis VJ, Pertiwi K, Ten Cate-Hoek AJ, Ten Cate H.

Thromb Haemost. 2018 Feb;118(2):229-250. doi: 10.1160/TH17-07-0492. Epub 2018 Jan 29.

37.

Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants.

Ten Cate H, Henskens YM, Lancé MD.

Vasc Health Risk Manag. 2017 Dec 13;13:457-467. doi: 10.2147/VHRM.S126265. eCollection 2017. Review.

38.

Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial.

Ten Cate-Hoek AJ, Amin EE, Bouman AC, Meijer K, Tick LW, Middeldorp S, Mostard GJM, Ten Wolde M, van den Heiligenberg SM, van Wissen S, van de Poel MH, Villalta S, Serné EH, Otten HM, Klappe EH, Bistervels IM, Lauw MN, Piersma-Wichers M, Prandoni P, Joore MA, Prins MH, Ten Cate H; IDEAL DVT investigators.

Lancet Haematol. 2018 Jan;5(1):e25-e33. doi: 10.1016/S2352-3026(17)30227-2. Epub 2017 Dec 5.

PMID:
29217387
39.

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians.

Douxfils J, Ageno W, Samama CM, Lessire S, Ten Cate H, Verhamme P, Dogné JM, Mullier F.

J Thromb Haemost. 2018 Feb;16(2):209-219. doi: 10.1111/jth.13912. Epub 2017 Dec 28. Review.

PMID:
29193737
40.

Screening for platelet function disorders with Multiplate and platelet function analyzer.

Moenen FCJI, Vries MJA, Nelemans PJ, van Rooy KJM, Vranken JRRA, Verhezen PWM, Wetzels RJH, Ten Cate H, Schouten HC, Beckers EAM, Henskens YMC.

Platelets. 2019;30(1):81-87. doi: 10.1080/09537104.2017.1371290. Epub 2017 Nov 14.

PMID:
29135309
41.

Routine haemostasis testing before transplanted kidney biopsy: a cohort study.

Kuiper GJAJM, Christiaans MHL, Mullens MHJM, Ten Cate H, Hamulýak K, Henskens YMC.

Transpl Int. 2018 Mar;31(3):302-312. doi: 10.1111/tri.13090. Epub 2017 Nov 21.

42.

Testing direct oral anticoagulants: embedding in structured long-term care.

Ten Cate H.

Blood Transfus. 2018 Sep;16(5):410-412. doi: 10.2450/2017.0197-17. Epub 2017 Oct 22. No abstract available.

43.

Intermediate and nonclassical monocytes show heterogeneity in patients with different types of acute coronary syndrome.

Leers MPG, Stockem C, Ackermans D, Loeffen R, Ten Cate H, Kragten JA, Jie KG.

Cytometry A. 2017 Nov;91(11):1059-1067. doi: 10.1002/cyto.a.23263. Epub 2017 Oct 11.

44.

Reversing Dabigatran Anticoagulation with Prothrombin Complex Concentrate versus Idarucizumab as Part of Multimodal Hemostatic Intervention in an Animal Model of Polytrauma.

Honickel M, Braunschweig T, Rossaint R, Stoppe C, Ten Cate H, Grottke O.

Anesthesiology. 2017 Nov;127(5):852-861. doi: 10.1097/ALN.0000000000001856.

PMID:
28857806
45.

Platelet populations and priming in hematological diseases.

Baaten CCFMJ, Ten Cate H, van der Meijden PEJ, Heemskerk JWM.

Blood Rev. 2017 Nov;31(6):389-399. doi: 10.1016/j.blre.2017.07.004. Epub 2017 Jul 22. Review.

PMID:
28756877
46.

Age-related diagnostic value of D-dimer testing and the role of inflammation in patients with suspected deep vein thrombosis.

Prochaska JH, Frank B, Nagler M, Lamparter H, Weißer G, Schulz A, Eggebrecht L, Göbel S, Arnold N, Panova-Noeva M, Hermanns I, Pinto A, Konstantinides S, Ten Cate H, Lackner KJ, Münzel T, Espinola-Klein C, Wild PS.

Sci Rep. 2017 Jul 4;7(1):4591. doi: 10.1038/s41598-017-04843-x.

47.

Empirically Reduced Dosages of Tinzaparin in Patients with Moderate-to-Severe Renal Insufficiency Lead to Inadequate Anti-Xa Levels.

Olie RH, Meertens NEL, Henskens YMC, Ten Cate H.

Nephron. 2017;137(2):113-123. doi: 10.1159/000477474. Epub 2017 Jun 30.

PMID:
28662505
48.

Microvesicles in vascular homeostasis and diseases.

Ridger VC, Boulanger CM, Angelillo-Scherrer A, Badimon L, Blanc-Brude O, Bochaton-Piallat ML, Boilard E, Buzas EI, Caporali A, Dignat-George F, Evans PC, Lacroix R, Lutgens E, Ketelhuth DFJ, Nieuwland R, Toti F, Tuñon J, Weber C, Hoefer IE, Lip GYH, Werner N, Shantsila E, Ten Cate H, Thomas M, Harrison P.

Thromb Haemost. 2017 Jul;117(7):1296-1316. doi: 10.1160/TH16-12-0943. Epub 2017 Nov 28. Review.

PMID:
30457157
49.

Coagulation factor and protease pathways in thrombosis and cardiovascular disease.

Ten Cate H, Hackeng TM, García de Frutos P.

Thromb Haemost. 2017 Jun 28;117(7):1265-1271. doi: 10.1160/TH17-02-0079. Epub 2017 Jun 8. Review.

PMID:
28594052
50.

Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis.

van der Hulle T, van Es N, den Exter PL, van Es J, Mos ICM, Douma RA, Kruip MJHA, Hovens MMC, Ten Wolde M, Nijkeuter M, Ten Cate H, Kamphuisen PW, Büller HR, Huisman MV, Klok FA.

Thromb Haemost. 2017 Jul 26;117(8):1622-1629. doi: 10.1160/TH17-02-0076. Epub 2017 Jun 1.

PMID:
28569924

Supplemental Content

Loading ...
Support Center